Public, NASDAQ:SNTS
NASDAQ Global Market
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Date: Mon, 06 Feb 2012 22:52:07 GMT
Tags:
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
EON: Enhanced Online News (press release) - 18 hours ago
EON: Enhanced Online News (press release) - 18 hours ago
SAN DIEGO--(EON: Enhanced Online News)--Santarus, Inc. (NASDAQ: SNTS) today announced that it has commenced promotion of prescription FENOGLIDE ® (fenofibrate) tablets 40 mg and 120 mg to selected physicians in the US FENOGLIDE is indicated as an ...
Santarus begins promoting cholesterol-lowering product
Date: Mon, 06 Feb 2012 17:18:27 GMT
Tags:
Santarus begins promoting cholesterol-lowering product
San Diego Source (subscription) - 23 hours ago
San Diego Source (subscription) - 23 hours ago
By Daily Transcript staff report San Diego-based Santarus Inc. (Nasdaq: SNTS) has begun promoting prescription fenoglide tablets, both 40 mg and 120 mg, to selected physicians in the United States.
Another Year, Another High...
Date: Mon, 06 Feb 2012 10:07:34 GMT
Tags:
Another Year, Another High...
NASDAQ - Feb 6, 2012
NASDAQ - Feb 6, 2012
(RTTNews.com) - The biotechnology sector, though a risky investment arena, offers a tremendous potential for huge gains. Binary events like clinical trial results and FDA decisions are typical in biotechnology companies, and can cause significant ...
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Date: Mon, 06 Feb 2012 09:04:54 GMT
Tags:
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
TheStreet.com (press release) - Feb 6, 2012
TheStreet.com (press release) - Feb 6, 2012
By Business Wire 02/06/12 - 04:00 AM EST Santarus, Inc. (NASDAQ: SNTS) today announced that it has commenced promotion of prescription FENOGLIDE ® (fenofibrate) tablets 40 mg and 120 mg to selected physicians in the US FENOGLIDE is indicated as an ...
Pharming Reports On Extraordinary General Meeting Of Shareholders
Date: Fri, 03 Feb 2012 20:59:17 GMT
Tags:
Pharming Reports On Extraordinary General Meeting Of Shareholders
PharmaLive (press release) (subscription) - Feb 3, 2012
PharmaLive (press release) (subscription) - Feb 3, 2012
Leiden, The Netherlands, February 3, 2012. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced that at its Extraordinary General shareholders Meeting (EGM) held today, all proposals were approved, ...
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Date: Mon, 06 Feb 2012 09:00:00 GMT
Tags:
[Business Wire] - Santarus, Inc. today announced that it has commenced promotion of prescription FENOGLIDE® tablets 40 mg and 120 mg to selected physicians in the U.S. FENOGLIDE is indicated as an adjunct to diet to reduce elevated low-density lipoprotein-cholesterol , total cholesterol, triglycerides and apolipoprotein B , and to increase high-density lipoprotein-cholesterol in adult patients with primary hyperlipidemia ...
5 Stocks Hitting New 52-Week Highs
Date: Wed, 11 Jan 2012 19:10:50 GMT
Tags:
Pharming redeems part of convertible bond
Date: Fri, 06 Jan 2012 06:02:04 GMT
Tags:
[Thomson Reuters ONE] - Leiden, The Netherlands, 06 January, 2012. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has redeemed part of its €8.4 ...
8 Healthcare Stocks With High P/E Ratios
Date: Thu, 29 Dec 2011 21:09:06 GMT
Tags:
Santarus' CEO Discusses Business Update Conference Call Transcript
Date: Thu, 22 Dec 2011 17:30:33 GMT
Tags:
[at Seeking Alpha] - Santarus' CEO Discusses Business Update Conference Call Transcript